APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Drug Discovery Market Outlook and Growth Opportunities 2026

4 June 2026203 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Market Analysis and Forecast 2026-2032237 pages · $4,950 USD

Market perspective

The global AI Drug Discovery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Discovery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Drug Discovery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Drug Discovery market include Recursion, Insilico Medicine, Schrödinger, DeepMind, Insitro, Generate Biomedicines, XtalPi, Relay Therapeutics and BenevolentAI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Drug Discovery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Discovery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Discovery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Drug Discovery market.

AI Drug Discovery Segment by Company

Recursion

Insilico Medicine

Schrödinger

DeepMind

Insitro

Generate Biomedicines

XtalPi

Relay Therapeutics

BenevolentAI

Roivant Sciences

Ginkgo Bioworks

Exscientia

Merck KGaA

Novartis

Biotus

Huazhi Bio

MindRank AI

Ubigene

WuXi AppTec

AI Drug Discovery Segment by Type

Machine Learning Type

Deep Learning Type

Natural Language Processing Type

Data Mining Type

AI Drug Discovery Segment by Application

Target Discovery and Validation

Virtual Screening and Molecular Docking

Drug Repurposing and Precision Medicine

Clinical Data Analysis and Optimization

AI Drug Discovery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Drug Discovery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Drug Discovery key companies, revenue, market share, and recent developments.

3. To split the AI Drug Discovery breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Drug Discovery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Drug Discovery significant trends, drivers, influence factors in global and regions.

6. To analyze AI Drug Discovery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Discovery industry.

Chapter 3: Detailed analysis of AI Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Drug Discovery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Drug Discovery Industry Trends Table 2. AI Drug Discovery Industry Drivers Table 3. AI Drug Discovery Industry Opportunities and Challenges Table 4. AI Drug Discovery Industry Restraints Table 5. Global AI Drug Discovery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Drug Discovery Revenue Share by Company (2021-2026) Table 7. Global AI Drug Discovery Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Drug Discovery Key Company Manufacturing Base & Headquarters Table 9. Global AI Drug Discovery Company, Product Type & Application Table 10. Global AI Drug Discovery Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Machine Learning Type Table 15. Significant Companies of Deep Learning Type Table 16. Significant Companies of Natural Language Processing Type Table 17. Significant Companies of Data Mining Type Table 18. Global AI Drug Discovery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI Drug Discovery Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI Drug Discovery Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI Drug Discovery Sales Value Share by Type (2021-2026) Table 22. Global AI Drug Discovery Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Target Discovery and Validation Table 24. Significant Companies of Virtual Screening and Molecular Docking Table 25. Significant Companies of Drug Repurposing and Precision Medicine Table 26. Significant Companies of Clinical Data Analysis and Optimization Table 27. Global AI Drug Discovery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI Drug Discovery Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global AI Drug Discovery Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global AI Drug Discovery Sales Value Share by Application (2021-2026) Table 31. Global AI Drug Discovery Sales Value Share by Application (2027-2032) Table 32. Global AI Drug Discovery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Drug Discovery Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global AI Drug Discovery Sales Value Share by Region (2021-2026) Table 35. Global AI Drug Discovery Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global AI Drug Discovery Sales Value Share by Region (2027-2032) Table 37. Global AI Drug Discovery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI Drug Discovery Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global AI Drug Discovery Sales Value Market Share by Country (2021-2026) Table 40. Global AI Drug Discovery Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global AI Drug Discovery Sales Value Market Share by Country (2027-2032) Table 42. Recursion Company Information Table 43. Recursion Business Overview Table 44. Recursion AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Recursion AI Drug Discovery Product Portfolio Table 46. Recursion Recent Development Table 47. Insilico Medicine Company Information Table 48. Insilico Medicine Business Overview Table 49. Insilico Medicine AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Insilico Medicine AI Drug Discovery Product Portfolio Table 51. Insilico Medicine Recent Development Table 52. Schrödinger Company Information Table 53. Schrödinger Business Overview Table 54. Schrödinger AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Schrödinger AI Drug Discovery Product Portfolio Table 56. Schrödinger Recent Development Table 57. DeepMind Company Information Table 58. DeepMind Business Overview Table 59. DeepMind AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. DeepMind AI Drug Discovery Product Portfolio Table 61. DeepMind Recent Development Table 62. Insitro Company Information Table 63. Insitro Business Overview Table 64. Insitro AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Insitro AI Drug Discovery Product Portfolio Table 66. Insitro Recent Development Table 67. Generate Biomedicines Company Information Table 68. Generate Biomedicines Business Overview Table 69. Generate Biomedicines AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Generate Biomedicines AI Drug Discovery Product Portfolio Table 71. Generate Biomedicines Recent Development Table 72. XtalPi Company Information Table 73. XtalPi Business Overview Table 74. XtalPi AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. XtalPi AI Drug Discovery Product Portfolio Table 76. XtalPi Recent Development Table 77. Relay Therapeutics Company Information Table 78. Relay Therapeutics Business Overview Table 79. Relay Therapeutics AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Relay Therapeutics AI Drug Discovery Product Portfolio Table 81. Relay Therapeutics Recent Development Table 82. BenevolentAI Company Information Table 83. BenevolentAI Business Overview Table 84. BenevolentAI AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. BenevolentAI AI Drug Discovery Product Portfolio Table 86. BenevolentAI Recent Development Table 87. Roivant Sciences Company Information Table 88. Roivant Sciences Business Overview Table 89. Roivant Sciences AI Drug Discovery Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Roivant Sciences AI Drug Discovery Product Portfolio Table 91. Roivant Sciences Recent Development Table 92. Ginkgo Bioworks Company Information Table 93. Ginkgo Bioworks Business Overview Table 94. Ginkgo Bioworks AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Ginkgo Bioworks AI Drug Discovery Product Portfolio Table 96. Ginkgo Bioworks Recent Development Table 97. Exscientia Company Information Table 98. Exscientia Business Overview Table 99. Exscientia AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Exscientia AI Drug Discovery Product Portfolio Table 101. Exscientia Recent Development Table 102. Merck KGaA Company Information Table 103. Merck KGaA Business Overview Table 104. Merck KGaA AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Merck KGaA AI Drug Discovery Product Portfolio Table 106. Merck KGaA Recent Development Table 107. Novartis Company Information Table 108. Novartis Business Overview Table 109. Novartis AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Novartis AI Drug Discovery Product Portfolio Table 111. Novartis Recent Development Table 112. Biotus Company Information Table 113. Biotus Business Overview Table 114. Biotus AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Biotus AI Drug Discovery Product Portfolio Table 116. Biotus Recent Development Table 117. Huazhi Bio Company Information Table 118. Huazhi Bio Business Overview Table 119. Huazhi Bio AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Huazhi Bio AI Drug Discovery Product Portfolio Table 121. Huazhi Bio Recent Development Table 122. MindRank AI Company Information Table 123. MindRank AI Business Overview Table 124. MindRank AI AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. MindRank AI AI Drug Discovery Product Portfolio Table 126. MindRank AI Recent Development Table 127. Ubigene Company Information Table 128. Ubigene Business Overview Table 129. Ubigene AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Ubigene AI Drug Discovery Product Portfolio Table 131. Ubigene Recent Development Table 132. WuXi AppTec Company Information Table 133. WuXi AppTec Business Overview Table 134. WuXi AppTec AI Drug Discovery Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. WuXi AppTec AI Drug Discovery Product Portfolio Table 136. WuXi AppTec Recent Development Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. AI Drug Discovery Product Image Figure 2. Global AI Drug Discovery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Drug Discovery Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Machine Learning Type Image Figure 8. Deep Learning Type Image Figure 9. Natural Language Processing Type Image Figure 10. Data Mining Type Image Figure 11. Global AI Drug Discovery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI Drug Discovery Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI Drug Discovery Sales Value Share by Type (2021-2032) Figure 14. Target Discovery and Validation Image Figure 15. Virtual Screening and Molecular Docking Image Figure 16. Drug Repurposing and Precision Medicine Image Figure 17. Clinical Data Analysis and Optimization Image Figure 18. Global AI Drug Discovery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI Drug Discovery Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global AI Drug Discovery Sales Value Share by Application (2021-2032) Figure 21. Global AI Drug Discovery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global AI Drug Discovery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America AI Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 24. North America AI Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe AI Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 26. Europe AI Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific AI Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific AI Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America AI Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 30. South America AI Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa AI Drug Discovery Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa AI Drug Discovery Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt AI Drug Discovery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt AI Drug Discovery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt AI Drug Discovery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Machine Learning Type
  • Deep Learning Type
  • Natural Language Processing Type
  • Data Mining Type
Applications
  • Target Discovery and Validation
  • Virtual Screening and Molecular Docking
  • Drug Repurposing and Precision Medicine
  • Clinical Data Analysis and Optimization
Companies covered
  • Recursion
  • Insilico Medicine
  • Schrödinger
  • DeepMind
  • Insitro
  • Generate Biomedicines
  • XtalPi
  • Relay Therapeutics
  • BenevolentAI
  • Roivant Sciences
  • Ginkgo Bioworks
  • Exscientia
  • Merck KGaA
  • Novartis
  • Biotus
  • Huazhi Bio
  • MindRank AI
  • Ubigene
  • WuXi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Drug Discovery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Drug Discovery Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Drug Discovery Market Dynamics
  1. 2.1 AI Drug Discovery Industry Trends
  2. 2.2 AI Drug Discovery Industry Drivers
  3. 2.3 AI Drug Discovery Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Industry Restraints
3 AI Drug Discovery Market by Company
  1. 3.1 Global AI Drug Discovery Company Revenue Ranking in 2025
  2. 3.2 Global AI Drug Discovery Revenue by Company (2021-2026)
  3. 3.3 Global AI Drug Discovery Company Ranking (2024-2026)
  4. 3.4 Global AI Drug Discovery Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Drug Discovery Company Product Type and Application
  6. 3.6 Global AI Drug Discovery Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Drug Discovery Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Drug Discovery Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Drug Discovery Market by Type
  1. 4.1 AI Drug Discovery Type Introduction
  2. 4.1.1 Machine Learning Type
  3. 4.1.2 Deep Learning Type
  4. 4.1.3 Natural Language Processing Type
  5. 4.1.4 Data Mining Type
  6. 4.2 Global AI Drug Discovery Sales Value by Type
  7. 4.2.1 Global AI Drug Discovery Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI Drug Discovery Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI Drug Discovery Sales Value Share by Type (2021-2032)
5 AI Drug Discovery Market by Application
  1. 5.1 AI Drug Discovery Application Introduction
  2. 5.1.1 Target Discovery and Validation
  3. 5.1.2 Virtual Screening and Molecular Docking
  4. 5.1.3 Drug Repurposing and Precision Medicine
  5. 5.1.4 Clinical Data Analysis and Optimization
  6. 5.2 Global AI Drug Discovery Sales Value by Application
  7. 5.2.1 Global AI Drug Discovery Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Drug Discovery Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Drug Discovery Sales Value Share by Application (2021-2032)
6 AI Drug Discovery Regional Value Analysis
  1. 6.1 Global AI Drug Discovery Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Drug Discovery Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Drug Discovery Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Drug Discovery Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Drug Discovery Sales Value (2021-2032)
  7. 6.3.2 North America AI Drug Discovery Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Drug Discovery Sales Value (2021-2032)
  10. 6.4.2 Europe AI Drug Discovery Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Drug Discovery Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Drug Discovery Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Drug Discovery Sales Value (2021-2032)
  16. 6.6.2 South America AI Drug Discovery Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Drug Discovery Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Drug Discovery Sales Value Share by Country, 2025 VS 2032
7 AI Drug Discovery Country-level Value Analysis
  1. 7.1 Global AI Drug Discovery Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Drug Discovery Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Drug Discovery Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Drug Discovery Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Drug Discovery Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Drug Discovery Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Drug Discovery Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Drug Discovery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Drug Discovery Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Drug Discovery Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Drug Discovery Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Drug Discovery Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Drug Discovery Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Drug Discovery Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Drug Discovery Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Drug Discovery Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Drug Discovery Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Drug Discovery Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Drug Discovery Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Drug Discovery Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Drug Discovery Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Drug Discovery Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Drug Discovery Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Drug Discovery Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Drug Discovery Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Drug Discovery Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Drug Discovery Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Drug Discovery Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Drug Discovery Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Drug Discovery Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Drug Discovery Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Drug Discovery Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Drug Discovery Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Drug Discovery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Recursion
  2. 8.1.1 Recursion Company Information
  3. 8.1.2 Recursion Business Overview
  4. 8.1.3 Recursion AI Drug Discovery Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Recursion AI Drug Discovery Product Portfolio
  6. 8.1.5 Recursion Recent Developments
  7. 8.2 Insilico Medicine
  8. 8.2.1 Insilico Medicine Company Information
  9. 8.2.2 Insilico Medicine Business Overview
  10. 8.2.3 Insilico Medicine AI Drug Discovery Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Insilico Medicine AI Drug Discovery Product Portfolio
  12. 8.2.5 Insilico Medicine Recent Developments
  13. 8.3 Schrödinger
  14. 8.3.1 Schrödinger Company Information
  15. 8.3.2 Schrödinger Business Overview
  16. 8.3.3 Schrödinger AI Drug Discovery Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Schrödinger AI Drug Discovery Product Portfolio
  18. 8.3.5 Schrödinger Recent Developments
  19. 8.4 DeepMind
  20. 8.4.1 DeepMind Company Information
  21. 8.4.2 DeepMind Business Overview
  22. 8.4.3 DeepMind AI Drug Discovery Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DeepMind AI Drug Discovery Product Portfolio
  24. 8.4.5 DeepMind Recent Developments
  25. 8.5 Insitro
  26. 8.5.1 Insitro Company Information
  27. 8.5.2 Insitro Business Overview
  28. 8.5.3 Insitro AI Drug Discovery Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Insitro AI Drug Discovery Product Portfolio
  30. 8.5.5 Insitro Recent Developments
  31. 8.6 Generate Biomedicines
  32. 8.6.1 Generate Biomedicines Company Information
  33. 8.6.2 Generate Biomedicines Business Overview
  34. 8.6.3 Generate Biomedicines AI Drug Discovery Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Generate Biomedicines AI Drug Discovery Product Portfolio
  36. 8.6.5 Generate Biomedicines Recent Developments
  37. 8.7 XtalPi
  38. 8.7.1 XtalPi Company Information
  39. 8.7.2 XtalPi Business Overview
  40. 8.7.3 XtalPi AI Drug Discovery Revenue and Gross Margin (2021-2026)
  41. 8.7.4 XtalPi AI Drug Discovery Product Portfolio
  42. 8.7.5 XtalPi Recent Developments
  43. 8.8 Relay Therapeutics
  44. 8.8.1 Relay Therapeutics Company Information
  45. 8.8.2 Relay Therapeutics Business Overview
  46. 8.8.3 Relay Therapeutics AI Drug Discovery Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Relay Therapeutics AI Drug Discovery Product Portfolio
  48. 8.8.5 Relay Therapeutics Recent Developments
  49. 8.9 BenevolentAI
  50. 8.9.1 BenevolentAI Company Information
  51. 8.9.2 BenevolentAI Business Overview
  52. 8.9.3 BenevolentAI AI Drug Discovery Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BenevolentAI AI Drug Discovery Product Portfolio
  54. 8.9.5 BenevolentAI Recent Developments
  55. 8.10 Roivant Sciences
  56. 8.10.1 Roivant Sciences Company Information
  57. 8.10.2 Roivant Sciences Business Overview
  58. 8.10.3 Roivant Sciences AI Drug Discovery Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Roivant Sciences AI Drug Discovery Product Portfolio
  60. 8.10.5 Roivant Sciences Recent Developments
  61. 8.11 Ginkgo Bioworks
  62. 8.11.1 Ginkgo Bioworks Company Information
  63. 8.11.2 Ginkgo Bioworks Business Overview
  64. 8.11.3 Ginkgo Bioworks AI Drug Discovery Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ginkgo Bioworks AI Drug Discovery Product Portfolio
  66. 8.11.5 Ginkgo Bioworks Recent Developments
  67. 8.12 Exscientia
  68. 8.12.1 Exscientia Company Information
  69. 8.12.2 Exscientia Business Overview
  70. 8.12.3 Exscientia AI Drug Discovery Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Exscientia AI Drug Discovery Product Portfolio
  72. 8.12.5 Exscientia Recent Developments
  73. 8.13 Merck KGaA
  74. 8.13.1 Merck KGaA Company Information
  75. 8.13.2 Merck KGaA Business Overview
  76. 8.13.3 Merck KGaA AI Drug Discovery Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Merck KGaA AI Drug Discovery Product Portfolio
  78. 8.13.5 Merck KGaA Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis AI Drug Discovery Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis AI Drug Discovery Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Biotus
  86. 8.15.1 Biotus Company Information
  87. 8.15.2 Biotus Business Overview
  88. 8.15.3 Biotus AI Drug Discovery Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biotus AI Drug Discovery Product Portfolio
  90. 8.15.5 Biotus Recent Developments
  91. 8.16 Huazhi Bio
  92. 8.16.1 Huazhi Bio Company Information
  93. 8.16.2 Huazhi Bio Business Overview
  94. 8.16.3 Huazhi Bio AI Drug Discovery Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Huazhi Bio AI Drug Discovery Product Portfolio
  96. 8.16.5 Huazhi Bio Recent Developments
  97. 8.17 MindRank AI
  98. 8.17.1 MindRank AI Company Information
  99. 8.17.2 MindRank AI Business Overview
  100. 8.17.3 MindRank AI AI Drug Discovery Revenue and Gross Margin (2021-2026)
  101. 8.17.4 MindRank AI AI Drug Discovery Product Portfolio
  102. 8.17.5 MindRank AI Recent Developments
  103. 8.18 Ubigene
  104. 8.18.1 Ubigene Company Information
  105. 8.18.2 Ubigene Business Overview
  106. 8.18.3 Ubigene AI Drug Discovery Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ubigene AI Drug Discovery Product Portfolio
  108. 8.18.5 Ubigene Recent Developments
  109. 8.19 WuXi AppTec
  110. 8.19.1 WuXi AppTec Company Information
  111. 8.19.2 WuXi AppTec Business Overview
  112. 8.19.3 WuXi AppTec AI Drug Discovery Revenue and Gross Margin (2021-2026)
  113. 8.19.4 WuXi AppTec AI Drug Discovery Product Portfolio
  114. 8.19.5 WuXi AppTec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst